Therapeutic results: report of the Hungarian children's leukaemia study group

Area of Science:

• Pediatric Oncology
• Hematology
• Epidemiology

Background:

• Leukemia is a significant health concern in pediatric populations.
• Understanding treatment outcomes and survival factors is crucial for improving pediatric cancer care.

Purpose of the Study:

• To determine the morbidity and treatment outcomes of childhood leukemia in Hungary.
• To identify key factors limiting survival in pediatric leukemia patients.

Main Methods:

• Retrospective analysis of pediatric leukemia cases in Hungary (0-15 years).
• Evaluation of complete remission rates for Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML).
• Analysis of factors impacting patient survival, including infections and radiation therapy.

Main Results:

• Leukemia morbidity in children aged 0-15 years in Hungary is 3.6/100,000.
• Complete remission rates were 88.5% for ALL and 57.1% for AML.
• Infections during induction therapy (91.3%) and Co irradiation (66.3%) were major factors limiting survival.

Conclusions:

• Childhood leukemia presents a notable challenge in Hungary, with specific remission rates for ALL and AML.
• Infectious complications and radiation therapy side effects are critical barriers to improving survival in pediatric leukemia patients.
• Targeted strategies to mitigate infection risks and manage treatment side effects are essential for enhancing outcomes in childhood leukemia.